In conclusion, related monogenic disorders of hypophosphatasia and acromegaly should be screened in the clinical assessment of patients with OPLL/DISH, and plasma PPi is a new biomarker enabling clinicians to screen OPLL/DISH patients for ENPP1 deficiency. This evidence concerns the gene ENPP1 and hyperinsulinemic hypoglycemia, familial, 4.